Basic Information
| RNALocate ID: | RLID:11003507 |
| RNA Symbol: | hsa-miR-671-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-671-5p |
| RNA ID: | miRBase:MIMAT0003880 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | B cell line (Raji)|Primary dendritic cells|T cell line (J77) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002537 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002538 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002539 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003506 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11003508 | Exosome | Plasma | 23663360 |
| RLID:11003509 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003510 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11003511 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11003512 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000555 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001431 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-671-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-66365 |
| MNDR | hsa-miR-671-5p | Oral squamous cell carcinoma | MNDR-E-MI-66366 |
| MNDR | hsa-miR-671-5p | B cell lymphoma of malt type | MNDR-E-MI-66367 |
| MNDR | hsa-miR-671-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-66368 |
| MNDR | hsa-miR-671-5p | Lymphoma | MNDR-E-MI-66369 |
| MNDR | hsa-miR-671-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-66370 |
| MNDR | hsa-miR-671-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-66371 |
| MNDR | hsa-miR-671-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-66372 |
| MNDR | hsa-miR-671-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-66373 |
| MNDR | hsa-miR-671-5p | Her2-receptor positive breast cancer | MNDR-E-MI-66374 |
| MNDR | hsa-miR-671-5p | Breast cancer luminal | MNDR-E-MI-66375 |
| MNDR | hsa-miR-671-5p | Prostate cancer | MNDR-E-MI-66376 |
| MNDR | hsa-miR-671-5p | Gastric cancer | MNDR-E-MI-66377 |
| MNDR | hsa-miR-671-5p | Alzheimer disease | MNDR-E-MI-66378 |
| MNDR | hsa-miR-671-5p | Intracranial aneurysm | MNDR-E-MI-66379 |
| MNDR | hsa-miR-671-5p | Lung cancer | MNDR-E-MI-66380 |
| MNDR | hsa-miR-671-5p | Parkinson disease | MNDR-E-MI-66381 |
| MNDR | hsa-miR-671-5p | Breast cancer | MNDR-E-MI-66382 |
| MNDR | hsa-miR-671-5p | Pituitary neoplasms | MNDR-E-MI-66383 |
| MNDR | hsa-miR-671-5p | Pancreatic cancer | MNDR-E-MI-66384 |
| MNDR | hsa-miR-671-5p | Melanoma | MNDR-E-MI-66385 |
| MNDR | hsa-miR-671-5p | Nephroblastoma | MNDR-E-MI-66386 |
| MNDR | hsa-miR-671-5p | Colon cancer | MNDR-E-MI-66387 |
| MNDR | hsa-miR-671-5p | Colon adenocarcinoma | MNDR-E-MI-66388 |
| MNDR | hsa-miR-671-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-66389 |
| MNDR | hsa-miR-671-5p | Familial ovarian cancer | MNDR-E-MI-66390 |
| MNDR | hsa-miR-671-5p | Prostate adenocarcinoma | MNDR-E-MI-66391 |
| MNDR | hsa-miR-671-5p | Carcinoma ductal breast | MNDR-E-MI-66392 |
| MNDR | hsa-miR-671-5p | Invasive ductal carcinoma | MNDR-E-MI-66393 |
| MNDR | hsa-miR-671-5p | Glioblastoma | MNDR-E-MI-66394 |
| MNDR | hsa-miR-671-5p | Glioma | MNDR-E-MI-66395 |
| MNDR | hsa-miR-671-5p | Chordoma | MNDR-E-MI-66396 |
| MNDR | hsa-miR-671-5p | Osteosarcoma | MNDR-E-MI-66397 |
| MNDR | hsa-miR-671-5p | Breast carcinoma | MNDR-E-MI-66398 |
| MNDR | hsa-miR-671-5p | Gastric adenocarcinoma | MNDR-E-MI-66399 |
| MNDR | hsa-miR-671-5p | Pituitary adenoma | MNDR-E-MI-66400 |
| MNDR | hsa-miR-671-5p | Lung squamous cell carcinoma | MNDR-E-MI-66401 |
| MNDR | hsa-miR-671-5p | Lung adenocarcinoma | MNDR-E-MI-66402 |
| MNDR | hsa-miR-671-5p | Thyroid carcinoma | MNDR-E-MI-66403 |
| MNDR | hsa-miR-671-5p | Bladder urothelial carcinoma | MNDR-E-MI-66404 |
| MNDR | hsa-miR-671-5p | Carcinoma renal cell | MNDR-E-MI-66405 |
| MNDR | hsa-miR-671-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-66406 |
| MNDR | hsa-miR-671-5p | Renal clear cell carcinoma | MNDR-E-MI-66407 |
| MNDR | hsa-miR-671-5p | Biliary tract cancer | MNDR-E-MI-66408 |
| MNDR | hsa-miR-671-5p | Esophageal cancer | MNDR-E-MI-66409 |
| MNDR | hsa-miR-671-5p | Prolactinoma | MNDR-E-MI-66410 |
| MNDR | hsa-miR-671-5p | Lung small cell carcinoma | MNDR-E-MI-66411 |
| MNDR | hsa-miR-671-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-66412 |
| MNDR | hsa-miR-671-5p | Adenoma | MNDR-E-MI-66413 |
| MNDR | hsa-miR-671-5p | Breast invasive carcinoma | MNDR-E-MI-66414 |
| MNDR | hsa-miR-671-5p | Progressive supranuclear palsy | MNDR-E-MI-66415 |
| MNDR | hsa-miR-671-5p | Hepatocellular carcinoma | MNDR-E-MI-66416 |
| MNDR | hsa-miR-671-5p | Embryonal cancer | MNDR-E-MI-66417 |
| MNDR | hsa-miR-671-5p | Familiar ovarian carcinoma | MNDR-E-MI-66418 |
| MNDR | hsa-miR-671-5p | B-cell lymphoma | MNDR-E-MI-66419 |
| MNDR | hsa-miR-671-5p | Malignant pleural mesothelioma | MNDR-E-MI-66420 |
| MNDR | hsa-miR-671-5p | Retinoblastoma | MNDR-E-MI-66421 |
| MNDR | hsa-miR-671-5p | Hodgkin lymphoma | MNDR-E-MI-66422 |
| MNDR | hsa-miR-671-5p | Skin cutaneous melanoma | MNDR-E-MI-66423 |
| MNDR | hsa-miR-671-5p | Skin melanoma | MNDR-E-MI-66424 |
| MNDR | hsa-miR-671-5p | Colorectal cancer | MNDR-E-MI-66425 |
| MNDR | hsa-miR-671-5p | Nasopharynx carcinoma | MNDR-E-MI-66426 |
| MNDR | hsa-miR-671-5p | Multiple myeloma | MNDR-E-MI-66427 |
| MNDR | hsa-miR-671-5p | Nasopharyngeal cancer | MNDR-E-MI-66428 |
| MNDR | hsa-miR-671-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-66429 |
| MNDR | hsa-miR-671-5p | Stroke lacunar | MNDR-E-MI-66430 |
| MNDR | hsa-miR-671-5p | Breast cancer her3+ negative | MNDR-E-MI-66431 |
| MNDR | hsa-miR-671-5p | Tubulovillous adenoma | MNDR-E-MI-66432 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CD44 | Homo sapiens | RR00301721 |
TOP